In the BioHarmony Drug Report Database

"Preview" Icon

Ergotamine

Medihaler Ergotamine (ergotamine) is a small molecule pharmaceutical. Ergotamine was first approved as Medihaler Ergotamine on 1982-01-01. It is used to treat cluster headache and migraine disorders in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 1D. In addition, it is known to target 5-hydroxytryptamine receptor 1F, 5-hydroxytryptamine receptor 5A, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2C, 5-hydroxytryptamine receptor 2A, and 5-hydroxytryptamine receptor 7.

 

Trade Name

 

Medihaler Ergotamine
 

Common Name

 

ergotamine
 

ChEMBL ID

 

CHEMBL442
 

Indication

 

cluster headache, migraine disorders
 

Drug Class

 

Image (chem structure or protein)

Ergotamine structure rendering